Oct 2024 - Viva Energy (ASX:VEA) posted solid sales growth for the third quarter of 2024, with group sales volumes rising by 3% year-on-year to 4.2 billion litres.

Many of the mistakes investors make are based on common sense rules of thumb that turn out to be wrong. As a result, it’s often wise for investors to turn common sense logic on its head. The easiest ...

View All Immutep News. Immutep - Annual report to shareholders. 22 Oct 2024 01:10 PM. On behalf of the Board, I’m pleased to present Immutep Limiteds ...

Mr James David Walker (Executive Chairman, Executive Director) ...

Oct 2024 - A snapshot of the stocks on the move, featuring Nanoveu (ASX:NVU), MoneyMe (ASX:MME) and Alicanto Minerals (ASX:AQI).

Oct 2024 - Praemium Limited (ASX:PPS) reported a robust start to FY25, with total Funds Under Administration (FUA) increasing by 33% to $59.4 billion as of 30 September 2024.

Oct 2024 - Immutep (ASX:IMM) has made significant progress over the past year with its lead immunotherapy candidate, eftilagimod alpha (efti).

Oct 2024 - The company’s pipeline for SOZO units increased by 34%, with 28 units sold in the US, a notable rise from the previous quarter’s 23 units.

Oct 2024 - Next Science Limited (ASX:NXS), a Sydney-based medical technology company, has reported a 7% dip in product sales for the third quarter of FY24, generating US$4.7 million.

Oct 2024 - Transurban (ASX:TCL) reported a 1.1% rise in average daily traffic (ADT) for the September 2024 quarter, reaching 2.5 million daily trips across its assets.

Oct 2024 - Australian semiconductor company BluGlass (ASX:BLG) has entered into a promising multi-phase Joint Development Agreement with Uviquity.

Oct 2024 - Mirvac Group (ASX:MGR) has made a strong start to FY25, driven by its residential and industrial segments and a $0.5 billion non-core asset sales program.